InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,254.11
(
-0.15%
)
US TECH 100
22,228.40
(
-0.10%
)
Dow Jones
44,501.24
(
0.10%
)
Brent Oil
68.57
(
-1.67%
)
Bitcoin
110,708.17
(
-0.52%
)
Post# of 216
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

chmcnfunds

Send PM Follow Ignore
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

chmcnfunds

Re: chmcnfunds post# 188

Thursday, 02/15/2018 9:38:12 AM

Thursday, February 15, 2018 9:38:12 AM

Post# of 216
So glad sold @ $89.10 yesterday toward the EOD. Analyst's darling and Baker Bro big holding but not the street favorite. Thought they had good quarterly, but something is amiss. Has been a personal loss despite buying down.

INCY
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent INCY News
More INCY News
InvestorsHub NewsWire

Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM

Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM

Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM

Start posting your company's news
Only $200 per official company press release!